Advertisement
Research Article Free access | 10.1172/JCI115685
Biochemistry Department, Whitaker Cardiovascular Institute, Boston University School of Medicine, Massachusetts 02118.
Find articles by Knowlton, A. in: JCI | PubMed | Google Scholar
Biochemistry Department, Whitaker Cardiovascular Institute, Boston University School of Medicine, Massachusetts 02118.
Find articles by Connelly, C. in: JCI | PubMed | Google Scholar
Biochemistry Department, Whitaker Cardiovascular Institute, Boston University School of Medicine, Massachusetts 02118.
Find articles by Romo, G. in: JCI | PubMed | Google Scholar
Biochemistry Department, Whitaker Cardiovascular Institute, Boston University School of Medicine, Massachusetts 02118.
Find articles by Mamuya, W. in: JCI | PubMed | Google Scholar
Biochemistry Department, Whitaker Cardiovascular Institute, Boston University School of Medicine, Massachusetts 02118.
Find articles by Apstein, C. in: JCI | PubMed | Google Scholar
Biochemistry Department, Whitaker Cardiovascular Institute, Boston University School of Medicine, Massachusetts 02118.
Find articles by Brecher, P. in: JCI | PubMed | Google Scholar
Published April 1, 1992 - More info
The expression of fibronectin in the repair process after myocardial infarction was studied using two protocols of coronary occlusion in the rabbit: a permanent occlusion or 3 h of occlusion followed by reperfusion (too late for salvage). We found a rapid and progressive increase in cardiac fibronectin expression in the infarcted region of the ventricle. Steady-state mRNA levels for fibronectin increased 13- and 16-fold, respectively, in the permanent and reperfused infarcts 1 d postinfarction. Immunological detection of the protein with a polyclonal antibody against plasma fibronectin showed significant increases of the protein fibronectin in the infarcted myocardium by day 3 in the reperfused group and by day 5 in the permanent coronary occlusion group. Ribonuclease protection assays established the induction of EIIIB containing fibronectin mRNA in both models by day 1 and use of a monoclonal antibody showed an increase in the EIIIA isoform 2 d postinfarction. Increases in steady-state mRNA levels for several collagen types were found in both groups, but these changes occurred after those noted for fibronectin. Thus fibronectin mRNA and protein expression increased rapidly postinfarction suggesting a functional role in the repair process.
Images.